Insider filing
Traded Mar 24 · filed 91 days later
Not classified as an open-market trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Jun 4, 2026 · Filed Jun 8, 2026
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
grant award
Code A — grant or award
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Insider filing
Traded Mar 24 · filed 91 days later
Not classified as an open-market trade.
Insider filing
Traded Mar 24 · filed 91 days later
Not classified as an open-market trade.
Insider buying
Traded Mar 24 · filed 91 days later
The CEO of Tempest Therapeutics paid $500K out of pocket for Tempest Therapeutics shares.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.